voriconazole has been researched along with medroxyprogesterone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Mikamo, H; Nishiyama, Y; Ohki, E; Satoh, K; Terada, M; Uchida, K; Yamagishi, Y; Yamaguchi, H | 1 |
1 review(s) available for voriconazole and medroxyprogesterone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for voriconazole and medroxyprogesterone
| Article | Year |
|---|---|
Fungal peritonitis associated with Curvularia geniculata and Pithomyces species in a patient with vulvar cancer who was successfully treated with oral voriconazole.
Topics: Antifungal Agents; Antineoplastic Agents; Ascomycota; Diabetic Nephropathies; Female; Humans; Immunocompromised Host; Medroxyprogesterone; Middle Aged; Mycoses; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole; Vulvar Neoplasms | 2014 |